leisure time -WSS

leisure time

author：fashion 2025-10-02 17:21:53 - browse：18897

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Wildfire pollution widens asthma inequities on Long Island

Wikipedia

WSS

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Covid's long

Mitch McConnell episode has important public health takeaway

Infectious disease expert Jeanne Marrazzo assumes Fauci role

NIH launches clinical trials and new research office for long Covid

Novo acquires Inversago for up to $1 billion

focus

leisure time

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Who are the detained American citizens released from prison in Iran?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sage hopes for a blockbuster in antidepressant now before FDA

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

How one medical school became remarkably diverse

Target recalls 2.2 million additional candles due to laceration, burn hazards

Dobbs anniversary: the lost opportunity of abortion as health care

National panel will explore requiring free Covid tests

knowledge

What the airline industry can learn from medicine

EQRx, failed developer of low

What the US credit downgrade means for the economy, your finances

Covid's long

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

EQRx, failed developer of low

hotspot

Wikipedia

focus

Wikipedia